SEC Company Response from Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704) (CLRB) — Jul 25, 2018
Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704)
Date: July 25, 2018 · CIK: 0001279704 · Accession: 0001144204-18-039888
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-225675
Letter
Ladenburg Thalmann & Co. Inc.
999 Vanderbilt Beach Road, Suite 200
Naples, Florida 34108
July 25, 2018
VIA FACSIMILE AND EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, DC 20549
Re: Cellectar Biosciences, INC.
Registration Statement on Form S-1 (Registration No. 333-225675)
Concurrence in Acceleration Request
Ladies and Gentlemen:
Ladenburg Thalmann & Co. Inc. (“Ladenburg”), as representative of the underwriters for the above-referenced offering, hereby concurs in the request by Cellectar Biosciences, Inc. that the effective date of the above-referenced registration statement be accelerated to 4:15 p.m. (Eastern Time), or as soon as practicable thereafter, on July 26, 2018, pursuant to Rule 461 under the Securities Act. Ladenburg affirms that it is aware of its obligations under the Securities Act in connection with this offering.
Very truly yours,
LADENBURG THALMANN & CO. INC.
Show Raw Text
CORRESP
1
filename1.htm
Ladenburg Thalmann & Co. Inc.
999 Vanderbilt Beach Road, Suite 200
Naples, Florida 34108
July 25, 2018
VIA FACSIMILE AND EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, DC 20549
Re: Cellectar
Biosciences, INC.
Registration Statement on Form
S-1 (Registration No. 333-225675)
Concurrence in Acceleration Request
Ladies and Gentlemen:
Ladenburg Thalmann
& Co. Inc. (“Ladenburg”), as representative of the underwriters for the above-referenced offering, hereby
concurs in the request by Cellectar Biosciences, Inc. that the effective date of the above-referenced registration statement be
accelerated to 4:15 p.m. (Eastern Time), or as soon as practicable thereafter, on July 26, 2018, pursuant to Rule 461 under the
Securities Act. Ladenburg affirms that it is aware of its obligations under the Securities Act in connection with this offering.
Very truly yours,
LADENBURG THALMANN & CO. INC.
By:
/s/ Nicholas Stergis
Name: Nicholas Stergis
Title: Managing Director